This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopj1 [2020/06/25 21:32] – jfpothier | bacteria:t3e:xopj1 [2025/07/04 23:36] (current) – jfpothier | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== XopJ1 ====== | + | ====== |
| - | Author: Jens Boch\\ | + | Author: |
| - | Internal reviewer: Joana Costa\\ | + | Internal reviewer: |
| - | Expert reviewer: | + | Expert reviewer: |
| Class: XopJ\\ | Class: XopJ\\ | ||
| Family: XopJ1\\ | Family: XopJ1\\ | ||
| - | Prototype: | + | Prototype: |
| - | RefSeq | + | GenBank |
| + | RefSeq ID: [[https:// | ||
| 3D structure: Unknown | 3D structure: Unknown | ||
| Line 15: | Line 16: | ||
| === How discovered? === | === How discovered? === | ||
| - | XopJ was initially discovered as a HrpG-induced gene in a cDNA-AFLP screen in // | + | XopJ was initially discovered as a HrpG-induced gene in a cDNA-AFLP screen in // |
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| A chimeric protein consisting of the 155 N-terminal amino acids of XopJ fused to an N-terminally truncated AvrBs3 is secreted out of the bacterial cell and elicits a hypersensitive response in a //Bs3// pepper plant. Secretion and translocation are dependent on components of the //Xcv// type III secretion system (//hrcV//) and translocon (//hrpF//) (Noël //et al//., 2003). The first 50 amino acids of XopJ are sufficient and the amino acids 2-8 required for secretion (Scheibner //et al//., 2018). This minimal secretion signal is not required for the interaction of XopJ with the effector chaperone HpaB or HrcQ from the bacterial type III secretion system (Scheibner //et al//., 2018). | A chimeric protein consisting of the 155 N-terminal amino acids of XopJ fused to an N-terminally truncated AvrBs3 is secreted out of the bacterial cell and elicits a hypersensitive response in a //Bs3// pepper plant. Secretion and translocation are dependent on components of the //Xcv// type III secretion system (//hrcV//) and translocon (//hrpF//) (Noël //et al//., 2003). The first 50 amino acids of XopJ are sufficient and the amino acids 2-8 required for secretion (Scheibner //et al//., 2018). This minimal secretion signal is not required for the interaction of XopJ with the effector chaperone HpaB or HrcQ from the bacterial type III secretion system (Scheibner //et al//., 2018). | ||
| + | |||
| === Regulation === | === Regulation === | ||
| //xopJ// is expressed in a //hrpG-// and // | //xopJ// is expressed in a //hrpG-// and // | ||
| + | |||
| === Phenotypes === | === Phenotypes === | ||
| - | Although a frameshift mutation of //xopJ// did not affect pathogenicity or bacterial growth in plants in early experiments (Noël //et al//., 2003), later studies showed that a //xopJ// mutant is slightly impaired in growth in pepper in late stages of the infection (Üstun //et al//., 2013). XopJ also suppresses | + | Although a frameshift mutation of //xopJ// did not affect pathogenicity or bacterial growth in plants in early experiments (Noël //et al//., 2003), later studies showed that a //xopJ// mutant is slightly impaired in growth in pepper in late stages of the infection (Üstun //et al//., 2013). XopJ also suppresses |
| === Localization === | === Localization === | ||
| - | Following type III translocation, | + | XopJ carries a predicted N-myristoylation motif on a glycine residue at position two of the polypeptide. |
| === Enzymatic function === | === Enzymatic function === | ||
| - | XopJ belongs to the group of YopJ-family effectors and is a member of the YopJ/AvrRxv family of SUMO peptidases and acetyltransferases. These are characterized as C55 cysteine proteases, ubiquitin-like proteases (deSUMOylation), | + | XopJ belongs to the group of YopJ-family effectors and is a member of the YopJ/AvrRxv family of SUMO peptidases and acetyltransferases. These are characterized as C55 cysteine proteases, ubiquitin-like proteases (deSUMOylation), |
| === Interaction partners === | === Interaction partners === | ||
| - | 19S RP subunit RPT6 (RP ATPase 6) of the 26S proteasome (Üstun | + | 19S RP subunit RPT6 (RP ATPase 6) of the 26S proteasome (Üstün |
| ===== Conservation ===== | ===== Conservation ===== | ||
| Line 48: | Line 55: | ||
| ===== References ===== | ===== References ===== | ||
| - | Bartetzko V, Sonnewald S, Vogel F, Hartner K, Stadler R, Hammes UZ, Börnke F (2009). The // | + | Bartetzko V, Sonnewald S, Vogel F, Hartner K, Stadler R, Hammes UZ, Börnke F (2009). The // |
| - | Noël L, Thieme F, Nennstiel | + | Noël L, Thieme F, Gäbler J, Büttner |
| - | Noël L, Thieme F, Gäbler J, Büttner | + | Noël L, Thieme F, Nennstiel |
| - | Scheibner F, Hartmann N, Hausner J, Lorenz C, Hoffmeister | + | Scheibner F, Hartmann N, Hausner J, Lorenz C, Hoffmeister |
| - | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | + | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // |
| - | Üstün S, Bartetzko V, Börnke F (2013). The // | + | Üstün S, Bartetzko V, Börnke F (2013). The // |
| + | |||
| + | Üstün S, Bartetzko V, Börnke F (2015). The // | ||
| Üstün S, Börnke F (2014). Interactions of // | Üstün S, Börnke F (2014). Interactions of // | ||
| Line 64: | Line 73: | ||
| Üstün S, Börnke F (2015). The // | Üstün S, Börnke F (2015). The // | ||
| - | Üstün S, Bartetzko V, Börnke F (2015). The // | + | White F, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // |
| + | |||
| + | ===== Acknowledgements ===== | ||
| - | White F, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). |